Aqdot Limited is a Cambridge (UK)-based supramolecular chemistry company with a focus and expertise in developing, licensing, and selling novel proprietary products. The company operates in two main areas: Aqdot Solutions, which works in partnership with customers to develop solutions utilizing the unique AqBit technology in various fields such as air filtering in transportation and delivery of therapeutics for cancer. On the other hand, Aqdot Products recently launched its own brands AqStar™ M1 and Oderase and collaborates with partners either for distribution or to develop market-specific formulations.
Founded in 2013, Aqdot Limited operates in the biotechnology industry with its headquarters in the United Kingdom. The company received a £7.00M Series C investment on 08 June 2020.
It is noteworthy that the last investment details regarding the investors were not provided.